Drugs in Figures III Study of public expenditure on the drug phenomenon
|
|
- Lee Fisher
- 5 years ago
- Views:
Transcription
1 Drugs in Figures III Study of public expenditure on the drug phenomenon Delfine Lievens Freya Vander Laenen Ghent University 1
2 1. METHODOLOGY Background Since 1990 s: increasing importance of the evaluation of drug policy and policy programmes Since 2001 EMCDDA underlines the importance of studies on public expenditure on drug policy European studies: Sweden (Ramstedt, 2002), Luxembourg (Origer, 2002), the Netherlands (Rigter, 2003), France (Kopp & Fenoglio, 2006), Germany (Mostardt et al. 2010),... Belgian studies: Drugs in Figures I (2004) & II (2007) 2
3 Objective Estimation of Belgian public expenditures (2008) for illegal drugs and legal drugs (new) Concept public expenditure: «the composition of the drug budget as an estimation of public authorities expenditures on the drug policy» 3
4 Methodology (cf. Drugs in figures I & II) ISSDP Utrecht Data collection: top-down and check on top-down Data processing: Drug specific Proration technique Unit expenditure Classification: labelled or non-labelled 4
5 Methodology Classification of Reuter (2004): 1. Prevention 2. Treatment 3. Enforcement 4. Harm reduction (Drugs in figures I & II) Other: coordination, research, 5
6 2. RESULTS Potential Uses of Expenditure Estimates National Belgian context: 2.1. One time period: comparison across sectors or comparison to policy pronouncements 2.2. Comparison over time International context: 2.3. Cross-country comparison 6
7 2.1. Belgian context: baseline estimate Pillar Baseline fractionof total expenditures (%) Low high fractions (%) Prevention 1,22 0,93-1,78 Treatment 77,14 69,58-81,08 Harm reduction 0,21 0,16-0,30 Enforcement 21,26 17,70-28,08 Other 0,18 0,14-0,26 Total 100 7
8 Belgian context: comparison across sectors 0,21% 1,22% 0,18% 21,26% 77,14% Treatment Enforcement Harm reduction Prevention Other 8
9 Belgian context:comparison across type of drug Pillar illegal drugs alcohol tobacco psychoactive medication Total Prevention 85,95 % 3,87 % 10,18 % / Treatment 19,04 % 76,05 % 0,26 % 4,65 % 100% 100% Harm reduction 100 % / / / 100% Enforcement 59,77 % 36,74 % 3,49 % / Other 94,90 % / 5,10 % / 100% 100% 9
10 2.2. Belgian context: comparison over time (illegal drugs) ISSDP Utrecht Pillar Prevention 3.82 % 3.64 % Treatment % % Harm reduction? 0.72 % Enforcement % % Other 0.36 % 0.59 % Total 100 % 100 % 10
11 2.2. Belgian context: comparison over time (illegal drugs) with similar proration techniques Pillar Prevention 3.82 % 2.79 % Treatment % % Harm reduction? 0.55 % Enforcement % % Other 0.36 % 0.45 % Total 100 % 100 % 11
12 2.3. Cross-country comparison (illegal drugs) Country Year Expenditure (billion euro) Sweden (Ramstedt) United States (ONDCP) Australia (Moore) Netherlands (Rigter) Germany (Mostardt) Proportion of GDP(%) ISSDP Utrecht Per capita ,95 0, ,7 0, ,2 0,41 160, ,19 0, ,2 6,1 0,23-0,26 63,17-74,11 Belgium ,31 0,09 28,94 12
13 Cross-country comparison (illegal drugs) ISSDP Utrecht Country Year Prevention Treatment Harm reduction Enforcement Other Sweden % 24 % 0,1 % 75 % / Netherlands % 13 % 9 % 76 % / Country Year Prevention Treatment Harm reduction Australia Enforcement Other 23 % 17 % 3 % 55 % 1 % Belgium ,6 % 51 % 0,7 % 44 % 0,6 % 13
14 Reflection Comparison Belgian expenditures across type of drug: Illegal drugs: 28,83 % Alcohol: 66,52 % Tobacco: 1,08 % Comparison Belgian expenditures (similar proration techniques): Prevention Treatment Enforcement 14
15 Reflection Public expenditure studies & drug policy: For policy purposes -> complexity + (non) favourable results Top down: 98,8%- Check on top down: 1,2% Labelled: 8% - Non-labelled: 92% (= estimates) For scientific purposes heavy on description light on analysis Methodology: Results vary depending on the used method Classification: labelled or non-labelled Data collection varies by type of drug 15
16 Want to read more? VANDER LAENEN, F., VANDAM, L., DE RUYVER, B., LIEVENS, D., Studies on public drug expenditure in Europe, possibilities and limitations, Bulletin on Narcotics, vol. LX, VAN MALDEREN, S., VANDER LAENEN, F., DE RUYVER, B., The study of expenditure on drugs, a useful evaluation tool for policy, in Cools et al., Gofs Research Paper Series, Contemporary Issues in the Empirical Study of Crime, DE RUYVER, B., VAN MALDEREN, S., VANDER LAENEN, F., "Study into public expenditures with regard to national drug policies. A feasible plan for the national focal points". Paper for the Expert Meeting on the Methodology to Estimate Drug- Related Expenditures in the European Union, December, 2007, Lisbon, organised by the EMCDDA,
A methodology for an EU cross-country comparison?
A methodology for an EU cross-country comparison? Public expenditure for drug treatment in hospitals dr. & prof. dr. Freya Vander Laenen Freya.Vanderlaenen@UGent.be Background 2 COMPARATIVE DRUG POLICY
More informationFeasibility study on drug consumption rooms in Belgium (DRUGROOM) Summary
Feasibility study on drug consumption rooms in Belgium (DRUGROOM) Summary CONTEXT Worldwide, harm reduction strategies are regarded an essential component of a comprehensive and integral drug policy (Cook
More informationHIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data -
HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data - EMCDDA annual expert meeting on drug-related deaths and drug-related infectious diseases 18/10 /2013 -
More informationIdentifying local harm reduction priorities: involving drug users and professionals
Identifying local harm reduction priorities: involving drug users and professionals September 24, 2015 Freya Vander Laenen t. f. +32 9 264 69 71 Background 2 Internationally, harm reduction interventions
More informationTHE SOCIAL COST OF LEGAL AND SUMMARY ILLEGAL DRUGS IN BELGIUM FREYA VANDER LAENEN, DELFINE LIEVENS, LIEVEN PAUWELS, WIM HARDYNS AND NELE SCHILS
THE SOCIAL COST OF LEGAL AND ILLEGAL DRUGS IN BELGIUM SUMMARY FREYA VANDER LAENEN, DELFINE LIEVENS, LIEVEN PAUWELS, WIM HARDYNS AND NELE SCHILS KOEN PUTMAN, LIEVEN ANNEMANS AND NICK VERHAEGHE TABLE OF
More informationPUBLIC EXPENDITURE ON SUPPLY REDUCTION POLICIES
Authors: Anne Line Bretteville-Jensen Claudia Costa Storti Thomas Kattau Sania Mikulic Fatima Trigueiros Fivos Papamalis Laura Piscociu Sergey Tsarev PUBLIC EXPENDITURE ON SUPPLY REDUCTION POLICIES PUBLIC
More informationIdentifying local harm reduction priorities: involving drug users and professionals
Identifying local harm reduction priorities: involving drug users and professionals September 24, 2015 Freya Vander Laenen t. f. +32 9 264 69 71 Background Harm reduction interventions are internationally
More informationCrime proofing and threat assessment - a methodological approach - differences and similarities
Crime proofing and threat assessment - a methodological approach - differences and similarities Prof. Dr. Tom Vander Beken EU Forum on the prevention of organised crime Workshop: A strategy on crime and
More informationTHE GOVERNMENTAL SUPERVISION AND MANAGEMENT
THE GOVERNMENTAL SUPERVISION AND MANAGEMENT OF EXPENDITURES REGARDING THE REALISATION AND EVALUATION OF DRUG POLICY DELFINE LIEVENS 2015 SUPERVISOR: PROF. DR. JOHAN CHRISTIAENS CO-SUPERVISOR: PROF. DR.
More informationClick for Support REALized
Click for Support REALized Newsletter #1: July 2017 1. Introduction In January 2017, the 2-year Click for Support REALized project (co-funded by the European Commission) with thirteen partner organisations
More informationMeasuring Illicit Tobacco Markets
3rd International Conference on Governance, Crime and Justice Statistics UNODC- INEGI Merida (Mexico) 7-10 June 2016 Measuring Illicit Tobacco Markets Ernesto U. Savona Director and Professor (ernesto.savona@unicatt.it)
More informationCriteria for the evaluation of crime prevention practices
European Crime Prevention Network Criteria for the evaluation of crime prevention practices QUALIPREV short manual October 2016 RESEARCHER Anneleen Rummens PROMOTORS Prof. dr. Wim Hardyns Prof. dr. Freya
More informationDrug Consumption Rooms Worldwide
Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationCAN HARM REDUCTION HELP SOLVE
CAN HARM REDUCTION HELP SOLVE THE PARADOX OF DRUG CONTROL? Lessons for Criminology and Crime Control Prof. Dr. Letizia Paoli, University of Leuven Eurocrim 2014, Prague, September 10-13, 2014 Drug control
More informationThomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.
European Comparative Alcohol Study Europe and Alcohol Policy Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.BO 220 FIN-00531
More informationManuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal
Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging
More informationThe Risk of Alcohol in Europe. Bridging the Gap June 2004
The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other
More informationKey Highlights continued
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationStrategies and coordination. in the field of drugs. in the European Union
Strategies and coordination in the field of drugs in the European Union A descriptive review EMCDDA November 2002 1 Strategies and coordination in the field of drugs in the European
More informationResearch paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union
Parliament of Montenegro Parliamentary Institute Research Centre Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union Podgorica, December
More informationDrug reform and regulation: a way out of the crisis?
PUBLIC HEARING Drug reform and regulation: a way out of the crisis? Speakers: Wednesday 8 December 2010 09.00-12.00 European Parliament ASP Building, Room A5E1 Hosted by Michail Tremopoulos, MEP Greens/EFA,
More informationHow does Active Mobility. Dr. Ute Winkler, Federal Ministry of Health, Germany
How does Active Mobility help to reach the SDGs? Dr. Ute Winkler, Federal Ministry of Health, Germany SDGs and Physical Activity Sustainable Development Goal 3: Ensure healthy lives and promote well-being
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationFear of Crime in the EU-15 & Hungary Assessing the Vulnerability, Victimization & Incivilities Model
Fear of Crime in the EU-15 & Hungary Assessing the Vulnerability, Victimization & Incivilities Model Christophe Vandeviver 11 th Annual Conference of the ESC Rethinking crime and punishment in Europe Panel
More informationUnderage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
More informationInjecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationGERMANY 2015 NATIONAL REPORT (2014 data) to the EMCDDA by the Reitox National Focal Point. Workbook Drug Policy
GERMANY 2015 NATIONAL REPORT (2014 data) to the EMCDDA by the Reitox National Focal Point Workbook Drug Policy Tim Pfeiffer-Gerschel, Lisa Jakob, Esther Dammer & Krystallia Karachaliou, IFT Institute for
More informationExtrapolation and potential impact of IPHS deployment in Europe
SIMPHS2 Validation Workshop Brussels, 31 Jan 2012 1 SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationDrug Money: the illicit proceeds of opiates trafficked on the Balkan route. Executive summary
Drug Money: the illicit proceeds of opiates trafficked on the Balkan route Executive summary 2015 Executive summary The cultivation, production and trafficking of illicit opiates accounted for almost
More informationMedia Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences
Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of
More informationAlcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol in Europe and Brief Intervention Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Global risk factors ranked by attributable burden of disease 2010 (GBD, Lancet,
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationTramadol-related deaths
Tramadol-related deaths 216 Survey overview European joint DRD expert meeting Lisbon, 29-3 September 216 Isabelle Giraudon, Federica Mathis, Klaudia Palczak Paralel workshop Opioids, medicines and focus
More informationPerspectives for information on alcohol use in the EU
EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco
More informationQuality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.
Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Yolande Lievens, MD, PhD Chair Radiation Oncology Department, Ghent University Hospital Co-Chair HERO
More informationPersonalized Medicine*: a health economist s view
Personalized Medicine*: a health economist s view Lieven Annemans Ghent University Lieven.annemans@ugent.be * or stratified, or targeted, or precision,.. Grimbergen, November 2014 1 We need to stimulate
More informationEU Report. Europe FEBRUARY 2017
H EU Report Europe FEBRUARY 2017 ANALYSIS OF HOTEL RULTS FEBRUARY 2017 The growth dynamic continues for hoteliers In February 2017, hospitality professionals posted improved results across Europe. The
More informationCOSTS AND UNINTENDED CONSEQUENCES OF DRUG CONTROL POLICIES
Authors: Anne Line Bretteville-Jensen Sania Mikulic Pavel Bem Fivos Papamalis Yossi Harel-Fisch Janusz Sieroslawski Fatima Trigueiros Laura Piscociu Sergey Tsarev Peyman Altan Claudia Costa Storti COSTS
More informationFinancing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011 Authors: Jennifer Kates (Kaiser Family Foundation), Adam Wexler (Kaiser Family
More informationFEDERAL RESEARCH PROGRAM ON DRUGS
1 FEDERAL RESEARCH PROGRAM ON DRUGS Policy recommendations ALCOLAW The Law of 2009 concerning the selling and serving of alcohol to youths: from state of the art to assessment Contract - DR/00/071 Coördinator
More informationReport on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs Report on the Risk Assessment of 4-MTA in the
More informationIntegrated harm reduction services for drug users and homeless people. Katrin Schiffer
Integrated harm reduction services for drug users and homeless people Katrin Schiffer Content Introduction Presentation of Correlation Network Harm Reduction in a nutshell basic principles and critical
More informationPrimary and secondary prevention of sudden cardiac death in emerging economies
Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationISSN ANNUAL REPORT THE STATE OF THE DRUGS PROBLEM IN EUROPE
ISSN 1609-6150 ANNUAL REPORT 2005 THE STATE OF THE DRUGS PROBLEM IN EUROPE EN ANNUAL REPORT THE STATE OF THE DRUGS PROBLEM IN EUROPE2005 Legal notice This publication of the European Monitoring Centre
More informationThe Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert
Albania. Algeria. Armenia. Austria. Belarus. Belgium. Bosnia & Herzegovina. Bulgaria. Croatia. Cyprus. Czech Republic Denmark. Egypt. Estonia. Finland. Former Yugoslav Republic of Macedonia. France. Georgia.
More informationISSN ANNUAL REPORT
ISSN 1609-6150 ANNUAL REPORT THE STATE OF THE DRUGS PROBLEM IN EUROPE2006 EN ANNUAL REPORT THE STATE OF THE DRUGS PROBLEM IN EUROPE2006 Legal notice This publication of the European Monitoring Centre
More informationAlcohol consumption, harm and policy responses in Europe. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe
Alcohol consumption, harm and policy responses in Europe Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe Burden of NCD in Europe Burden of disease by broad cause group
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /04 CORDROGUE 59
COUNCIL OF THE EUROPEAN UNION Brussels, 7 July 2004 11267/04 CORDROGUE 59 I/A ITEM NOTE from : General Secretariat to : COREPER/Council Subject : Draft Council Resolution on Cannabis 1. At its meeting
More informationDrug trafficking via the darknet. Chloé Carpentier Chief, Drug Research Section 23 October 2018
Drug trafficking via the darknet Chloé Carpentier Chief, Drug Research Section 23 October The darknet Identity of darknet users is hidden (TOR - The Onion Router ) Trading platforms where drugs can be
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 30 June /04 CORDROGUE 53
COUNCIL OF THE EUROPEAN UNION Brussels, 30 June 2004 10999/04 CORDROGUE 53 NOTE from : Netherlands presidency to : Horizontal Working Party on Drugs No. prev. doc. : 9595/04 CORDROGUE 36 + REV 1 Subject
More informationCase study examining the impact of German reunification on life expectancy
Supplementary Materials 2 Case study examining the impact of German reunification on life expectancy Table A1 summarises our case study. This is a simplified analysis for illustration only and does not
More informationCannabis policies & cannabis use
Cannabis policies & cannabis use Point of departure Does an increased interest in cannabis regulation result in the tendency to view the world through a lens that gives an over emphasis to, or over simplifies,
More informationHearing Loss: The Statistics
: The Statistics 2015 Global Statistics It is hard to know precise numbers of how many people experience hearing loss across the EU, Europe, and indeed the world. There are many sources of information
More informationPrimary Palliative Care Task Force. Update 3,Montreal, Oct Taskforce Members. Scott Murray, Scotland Eric van Rijswijk, Holland
Primary Palliative Care Task Force Update 3,Montreal, Oct 2013 Taskforce Members Scott Murray, Scotland Eric van Rijswijk, Holland Nils Schneider, Bart Van den Eynden, Xavier Gomez, Trine Brogaard, Tiago
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationMagyar Nemzeti Szívalapítvány Hungarian National Heart Foundation
Magyar Nemzeti Szívalapítvány Hungarian National Heart Foundation founded by the Hungarian Association of Cardiologists Tax No: Számlaszám/Bank account: Internet 18049471-2-42 11732002-20346146 www.mnsza.hu;
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationFemale genital mutilation: estimating girls at risk. Jurgita Peciuriene
Female genital mutilation: estimating girls at risk Jurgita Peciuriene EU framework Resolution 2012 on ending FGM Resolution 2014 on the Commission communication Towards the elimination of FGM Web-platform
More informationCorrection to: The education gradient in cancer screening participation: a consistent phenomenon across Europe?
International Journal of Public Health https://doi.org/10.1007/s00038-018-1141-3 (0456789().,-volV)(0456789().,-volV) CORRECTION Correction to: The education gradient in cancer screening participation:
More informationSign Language Act in Europe and Hungary by dr. Ádám Kósa
Sign Language Act in Europe and Hungary by dr. Ádám Kósa Member of the European Parliament co-chair of the Disability Intergroup president of the Hungarian Association of the Deaf and Hard-of- Hearing
More informationTEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée
Teddy Network of Excellence Annagrazia ALTAVILLA TEDDY Task-force in Europe for Drug Development for the Young Ph.D. Sciences Ethics LL.M. Health Law Associated Senior Lecturer Université de la MéditerranM
More informationPerspectives and Best Practices regarding Alcohol Prevention.
Perspectives and Best Practices regarding Alcohol Prevention. Picture: Porin Pakka Alcohol Harm Alcohol is the 3 rd top risk factor in Europe for ill health and NCDs such as cancer and cardiovascular disease
More informationPROBLEMATIC USE OF (ILLEGAL) DRUGS
PROBLEMATIC USE OF (ILLEGAL) DRUGS A STUDY OF THE OPERATIONALISATION OF THE CONCEPT IN A LEGAL CONTEXT SUMMARY 1. Introduction The notion of problematic drug use has been adopted in Belgian legislation
More informationDonor Government Funding for HIV in Low- and Middle-Income Countries in 2017
July 2018 Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017 Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Georgetown University, Center for Global Health Science
More informationMENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division
MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division The costs of poor mental health Estimates of Direct and Indirect Costs of Mental Illness 1 All
More informationWhat the AMPHORA project says for European alcohol policy
AMPHORA NEWSLETTER DECEMBER 2012 What the AMPHORA project says for European alcohol policy Potential impact The main outcomes of the scientific work of the AMPHORA project drive the need for stepped-up
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationAngela Me Chief Statistics and Survey Section UNODC
European Parliament Special Committee on organized crime, corruption and money laundering Brussels, 11-12 July 2012 Angela Me Chief Statistics and Survey Section UNODC No significant change in global status
More informationIdentifying Europe s information needs for effective drug policy Lisbon, EMCCDA
Cannabis Market in Europe: A Growing Domestic Market (First Results) Jean-Michel Costes, Christian Ben Lakhdar OFDT 3 avenue du Stade de France 93218 Saint-Denis La Plaine cedex Tel : 01 41 62 77 16 Fax
More informationEMCDDA trend report for the evaluation of the EU drugs strategy
EMCDDA trend report for the evaluation of the 2005 12 EU drugs strategy Contents Executive summary...4 Drug use and drug-related problems...4 Drug supply and new drugs...6 Drug policies...7 Demand reduction...8
More informationUK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
More informationBurden and cost of alcohol, tobacco and illegal drugs globally and in Europe
Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada
More informationIdentifying Common Ground on Public Health for UNGASS 2016:
Identifying Common Ground on Public Health for UNGASS 2016: What does a public health approach to global drug policy mean in practice? 21 April 2015, United Nations Headquarters Concept Note As momentum
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMUNICATION FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.10.2004 COM(2004)707 final COMMUNICATION FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMT on the results of the final evaluation of the EU
More informationMONITORING DRUG POLICY OUTCOMES: The Measurement of Drug-related Harm
THE BECKLEY FOUNDATION DRUG POLICY PROGRAMME MONITORING DRUG POLICY OUTCOMES: The Measurement of Drug-related Harm Marcus Roberts, Dave Bewley-Taylor and Mike Trace JULY 2006 REPORT NINE Report 9 1 MONITORING
More informationHana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)
The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) Why Do We Study the Cost of Smoking? To assess the economic impact of smoking behavior
More informationCannabis Legalization in Alberta
Cannabis Legalization in Alberta Regulation and Supply Chain Roundtable #3 Discussion Topics Potential for cannabis cafes or lounges Public education priorities Potential for economic development Alberta
More informationWhere we stand in EFORT
Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section
More informationFACT SHEET. A selection of internet-based information. Methedrone (bk-pmma)
FACT SHEET A selection of internet-based information Methedrone (bk-pmma) Scientific Institute of Public Health Drugs and Illegal Substances Program National Focal Point on Drugs Juliette Wytsmanstreet
More informationAlcohol Under 21 years old. Rory M Doyle, M.Sc Office of the Chief Medical Examiner Washington, DC
Alcohol Under 21 years old Rory M Doyle, M.Sc Office of the Chief Medical Examiner Washington, DC Rory.Doyle@dc.gov EU Drinking Age Limits Country Drinking age Purchase Age Country Drinking Age Purchase
More informationCannabis under control:
Cannabis under control: 1 cannabis social clubs as a regulated, non-profit model on the local level Prof. Dr. Tom Decorte Professor of criminology Institute for Social Drug research (ISD) - Ghent University
More informationPresent and potential perspectives for information on alcohol use in the EU
EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting Topics in this presentation 1.- EMCDDA overview and its work on
More informationCost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,
Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson
More informationMoving towards 2020 priorities for Public Health for the years Health and Consumers
Moving towards 2020 priorities for Public Health for the years 2013-20 Health in the MFF 2014-2020 Commission proposal for the Health for Growth Programme 2014-2020 http://ec.europa.eu/health/programme/policy/index_en.htm
More informationMarijuana in Washington, DC. Arrests, Usage, and Related Data
Marijuana in Washington, DC Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org November 5, 2009 1 Introduction This state report is part of a comprehensive
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationPost-test of the advertising campaign Help
Post-test of the advertising campaign Help Results Contact : Patrick KLEIN Tél : 01 41 98 97 20 Port : 06 09 64 33 e-mail : patrick.klein@ipsos.com December 2005 Contents Methodology 3 Recall and Liking
More informationCOUNCIL. Official Journal of the European Union. (Information) EU Drugs Action Plan ( ) (2005/C 168/01) Introduction
8.7.2005 EN C 168/1 I (Information) COUNCIL EU Drugs Action Plan (2005-2008) (2005/C 168/01) Introduction The drugs phenomenon is one of the major concerns of the citizens of Europe and a major threat
More informationImplementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.
SPECIAL REPORT Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report Summary www.ecdc.europa.eu ECDC SPECIAL REPORT Implementing the Dublin
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More information2007 NATIONAL REPORT (2006 data) TO THE EMCDDA by the Reitox National Focal Point BELGIUM
Scientific Institute of Public Health Unit of Epidemiology 2007 NATIONAL REPORT (2006 data) TO THE EMCDDA by the Reitox National Focal Point BELGIUM New developments, trends and in-depth information on
More information